BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
27.03
-0.86 (-3.08%)
At close: Nov 17, 2026

SHA:688166 Revenue

BrightGene Bio-Medical Technology had revenue of 315.48M CNY in the quarter ending September 30, 2026, a decrease of -6.33%. This brings the company's total for the last twelve months to 1.34B, up 13.81% year-over-year. In the year 2025, BrightGene Bio-Medical Technology had annual revenue of 1.22B, down -4.59%. That makes BrightGene Bio-Medical Technology the 17,474th largest company in the world by revenue and 3,176th in China.

Revenue (ttm)
1.34B
Revenue Growth
+13.81%
P/S Ratio
9.04
Revenue / Employee
1.12M
Employees
1,199
Market Cap
11.76B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Income from sale of Products 1.08B 90.7%
  • Equity Share Income 66.07M 5.6%
  • Income from Technology 44.46M 3.7%

By Geography

Chart
  • China 669.79M 56.3%
  • Export 519.71M 43.7%
Fiscal year ended Dec 31, 2025 See the full SHA:688166 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.22B-58.91M-4.59%
Dec 31, 20241.28B103.03M8.74%
Dec 31, 20231.18B162.19M15.94%
Dec 31, 20221.02B-35.08M-3.33%
Dec 31, 20211.05B267.03M34.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.